Skip to main content
Clinical Trials/CTRI/2022/05/042588
CTRI/2022/05/042588
Not yet recruiting
未知

Comparison of intravenous and intrathecal dexmedetomidine as adjuvants to 0.5% hyperbaric bupivacaine for post operative analgesia in abdominal hysterectomy.

JLN medical college and hospital0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: O- Medical and Surgical
Sponsor
JLN medical college and hospital
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
JLN medical college and hospital

Eligibility Criteria

Inclusion Criteria

  • 1\.body weight 40 to 80 kg.
  • 2\.Patient belonging to ASA class I and II.
  • 3\.Patient undergoing abdominal surgery.

Exclusion Criteria

  • 1\.Patient refusal or uncooperative patient.
  • 2\.Any known hypersensitivity or contraindication to bupivacaine, dexmedetomidine.
  • 3\.Local pathology at the site of injection or disability limiting the performance of spinal block.
  • History of convulsion, bleeding disorder, severe neurological deficit, thyroid disorder.
  • Patient with history of respiratory,cardiac,hepatic or renal disease.
  • Patient having a history of significant neurological,psychiatric or neuromuscular disorders.

Outcomes

Primary Outcomes

Not specified

Similar Trials